6569.TWO Onyx Healthcare Inc.
- Market cap
- TWD 3.49B
- P/E
- 17.7x
- P/B
- 2.40x
- ROE
- 13.3%
- Dividend yield
- 4.42%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 6569.TWO undervalued?
Graham number6569.TWO trades 37.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Onyx Healthcare Inc. fundamental analysis
No fundamental analysis for Onyx Healthcare Inc. yet.
Onyx Healthcare Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Onyx Healthcare Inc.
Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally. The company offers medical AI computer; medical tablet, power bank, and display; and medical panel and box PC. It also provides ODM/OEM services; smart view medical stations; fan less slim panel PC; medical display; healthcare infotainment; and medical pc …
Full company profileOnyx Healthcare Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Onyx Healthcare Inc. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.48B | 1.35B | 1.20B | 1.60B | 1.49B | 1.24B | 1.31B | 1.61B |
| Gross Profit | 543M | 464M | 364M | 472M | 556M | 456M | 434M | 521M |
| Operating Income | 248M | 206M | 144M | 244M | 308M | 90.5M | 50.3M | 93.2M |
| EBITDA | 319M | 236M | 171M | 271M | 332M | 231M | 148M | 261M |
| Net Income | 239M | 167M | 128M | 203M | 255M | 181M | 112M | 206M |
| EPS | 7.80 | 4.71 | 3.70 | 5.39 | 6.60 | 4.68 | 2.87 | 5.28 |
| Balance Sheet | ||||||||
| Total Assets | 1.38B | 1.39B | 1.70B | 1.97B | 2.05B | 2.11B | 2.15B | 2.36B |
| Total Liabilities | 359M | 340M | 667M | 566M | 528M | 553M | 584M | 814M |
| Shareholders' Equity | 1.01B | 1.04B | 1.03B | 1.39B | 1.51B | 1.54B | 1.57B | 1.55B |
| Cash & Short-term Investments | 409M | 398M | 193M | 336M | 410M | 325M | 374M | 261M |
| Total Debt | - | 9.40M | 316M | 192M | 207M | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 376M | 191M | 17.1M | 162M | 350M | 125M | 162M | -252M |
| Capital Expenditure | 8.82M | 16.8M | 296M | 15.1M | 68.0M | 7.08M | 14.3M | 23.3M |
| Free Cash Flow | 368M | 174M | -279M | 147M | 283M | 117M | 147M | -276M |
| Ratios | ||||||||
| ROE | 23.7% | 16.0% | 12.4% | 14.6% | 16.9% | 11.7% | 7.1% | 13.3% |
| ROA | 17.4% | 12.0% | 7.5% | 10.3% | 12.5% | 8.6% | 5.2% | 8.7% |
| Net Profit Margin | 16.1% | 12.4% | 10.6% | 12.7% | 17.1% | 14.6% | 8.5% | 12.8% |
| Debt to Equity | - | 0.01x | 0.31x | 0.14x | 0.14x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Onyx Healthcare Inc. dividends
- Dividend yield
- 4.42%
- Forward dividend
- 3.00 TWD
- Payout ratio
- 137.8%
- Ex-dividend date
- Jun 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 155M | 3.96 | 137.8% |
| 2024 | TWD 168M | 4.34 | 92.6% |
| 2023 | TWD 166M | 4.30 | 65.2% |
| 2022 | TWD 133M | 3.54 | 65.6% |
| 2021 | TWD 151M | 4.39 | 118.6% |
| 2020 | TWD 132M | 3.72 | 79.0% |
| 2019 | TWD 130M | 4.24 | 54.3% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1149.9016:1000 on Aug 1, 2024.
Who owns Onyx Healthcare Inc.
- Insiders 70.71%
- Institutions 0.01%
- Public & others 29.28%
- Shares outstanding 42.8M
- Free float 10.1M
Onyx Healthcare Inc. company profile
- Company name
- Onyx Healthcare Inc.
- Ticker
- 6569.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- No.135, Lane 235, New Taipei City, Taiwan, 231028
- Phone
- 886 2 8919 2188
- Website
- onyx-healthcare.com
About Onyx Healthcare Inc.
Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally. The company offers medical AI computer; medical tablet, power bank, and display; and medical panel and box PC. It also provides ODM/OEM services; smart view medical stations; fan less slim panel PC; medical display; healthcare infotainment; and medical pc and mobile computing cart. The company was incorporated in 2010 and is based in New Taipei City, Taiwan.
Onyx Healthcare Inc. management
4- Fu-Chung ChuangPresident & Director
- Ms. Hsiang-Chih YangHead of Accounting
- Mr. Ying-Te ChenDirector of Product & Marketing
- Mr. Hsing-Kuo ChaoHead of Product R&D Division